Analysts' Actions: Caterpillar, Coca-Cola, Wells Fargo and More

NEW YORK (TheStreet) -- RATINGS CHANGES Akamai was downgraded at Pacific Crest to sector perform. Traffic growth should continue to slow down in 2015, Pacific Crest said. Alexion was downgraded at Morgan Stanley to equal-weight from overweight. Twelve-month price target is $202. Valuation call, as the company has limited near-term catalysts, Morgan Stanley said. Must Read: When Must I Buy a Stock to Get the Dividend? Amgen was downgraded at Morgan Stanley to equal-weight from overweight. Twelve-month price target is $177. Valuation call, as the company lacks near-term catalysts, Morgan Stanley said. Baxter was downgraded at Morgan Stanley to underweight from equal-weight. Twelve-month price target is $73. Valuation call, as consensus expectations appear too high, Morgan Stanley said. CR Bard was upgraded at Morgan Stanley to equal-weight from underweight. Twelve-month price target is $187. Company has significant earnings flexibility, Morgan Stanley said. Boston Scientific was upgraded at J.P. Morgan to overweight from neutral. Stock lagged last year, but performance should improve in the coming months, J.P. Morgan said. Buffalo Wild Wings was downgraded at Robert Baird to neutral from outperform. Valuation call, based on a 12-month price target of $180, Baird said. Caterpillar was downgraded at J.P. Morgan to underweight from neutral. Twelve-month price target is $80. Exposure to energy and mining should be a growth headwind, J.P. Morgan said. Chicopee Bancorp was upgraded to buy at TheStreet Ratings. You can view the full analysis from the report here: CBNK Ratings Report. Coca-Cola Enterprises was upgraded at Bank of America/Merrill Lynch to buy from neutral. Valuation call, based on a 12-month price target of $52, Bank of America/Merrill Lynch said. CF Industries was upgraded at Piper Jaffray to overweight from neutral. Twelve-month price target is $327. Nitrogen nutrient fundamentals appear favorable, Piper Jaffray said. Cognizant was upgraded at Goldman Sachs to buy from neutral. Company has attractive exposure to the health care market and can continue to grow faster than its peers, Goldman Sachs said. Cablevision was downgraded at J.P. Morgan to underweight from neutral. Stock has exceeded the 12-month price target of $18, and the company is facing increased competition, J.P. Morgan said. Dr. Pepper Snapple was downgraded at Bank of America/Merrill Lynch to underperform from neutral. Valuation call, as the stock was up more than 49% in 2014, Bank of America/Merrill Lynch said. Twelve-month price target is $76. Must Read: CES 2015: What to Expect From the Biggest Tech Show of the Year F5 Networks was upgraded at Oppenheimer to outperform from perform. Twelve-month price target is $160. Checks point to strong business momentum, Oppenheimer said. General Mills was downgraded at Bank of America/Merrill to underperform from neutral. Twelve-month price target is $53. Stock is already pricing in an earnings recovery in the second half of the year, Bank of America/Merrill Lynch said. Green Plains was downgraded at Piper Jaffray to neutral from overweight. Twelve-month price target is $28. Falling ethanol prices should hurt margins, Piper Jaffray said. Gap was upgraded at Jefferies to buy from hold. Old Navy continues to grow, and the company should benefit from lower cotton prices, Jefferies said. Twelve-month price target is $50. Informatica was downgraded at Wedbush to neutral from outperform. Twelve-month price target is $37. Checks suggest the company is still facing execution problems, Wedbush said. Intel was upgraded at MKM Partners to buy from neutral. Twelve-month price target is $45. Estimates were also increased, given more stable PC demand, MKM Partners said. Coca-Cola was upgraded at Morgan Stanley to overweight. Twelve-month price target is $47. Recent strategy changes should improve fundamentals and lead to a higher valuation, Morgan Stanley said. LPL Financial was upgraded at Wells Fargo to market perform from outperform. Company is seeing higher sales and can begin to cut costs, Wells Fargo said. Lululemon was upgraded at William Blair to outperform. Estimates were also increased, as high comp sales should boost margins. PG&E was upgraded at Barclays to overweight from equal-weight. Twelve-month price target is $60. Regulatory matters should soon be resolved, Barclays said. PPL was downgraded at Jefferies to hold from buy. Twelve-month price target is $37. Expect lower earnings in the U.K. businesses, Jefferies said. Regeneron was upgraded at Morgan Stanley to overweight from equal-weight. Twelve-month price target is $485. Eyela should exceed expectations and drive near-term growth, Morgan Stanley said. Select Medical was downgraded at Robert Baird to neutral from outperform. Twelve-month price target is $14. 2015 should be a transition year for the company, Robert Baird said. SI Financial was upgraded to buy at TheStreet Ratings. You can view the full analysis from the report here: SIFI Ratings Report. Must Read: Why SAP, Accenture, Splunk Are Poised for Humongous Growth Teleflex was downgraded at Morgan Stanley to equal-weight from overweight. Twelve-month price target is $127. Company may struggle to meet consensus expectations, Morgan Stanley said. Texas Roadhouse was downgraded at Miller Tabak to hold. Valuation call, based on a 12-month price target of $34, Miller Tabak said. Wells Fargo was downgraded at Robert Baird to neutral from outperform. Valuation call, Robert Baird said. West was downgraded at Goldman Sachs to neutral from buy. Company is facing multiple growth headwinds, Goldman said. Zimmer was upgraded at J.P. Morgan to overweight from neutral. Twelve-month price target is $136. Management can unlock value, by integrating the Biomet purchase, J.P. Morgans said. Zimmer was upgraded at Morgan Stanley to overweight from equal-weight. Twelve-month price target is $134. Valuation call, as Biomet should help drive growth, Morgan Stanley said. Must Read: Billionaires Got Burned by These Six Struggling Stocks in 2014 Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes," which is available only to Real Money subscribers. To find out how to become a subscriber, please click here. Follow TheStreet on Twitter and become a fan on Facebook.

Click to view a price quote on AKAM. Click to research the Internet industry.

from Latest TSC Headlines http://ift.tt/1tD4itR